Intelligent blister packaging recognises and saves tablet removal

Schreiner MediPharm has developed intelligent blister packaging with printed electronics to help patients take their medication more reliably. Tablet withdrawals are automatically recognised and stored. Interactive communication with patients is made possible.
New intelligent blister packaging from Schneider MediPharm New intelligent blister packaging from Schneider MediPharm
The new intelligent blister pack from Schneider MediPharm recognises tablet withdrawals automatically. (Image: SchneiderMedipharm)

Schreiner MediPharm from Oberschleissheim has developed intelligent blister packaging designed to help patients take their medication more reliably. The solution was developed together with the Dutch technology company „Experts in Communications and Connectivity Technology“ (ECCT). It is being used by an international pharmaceutical manufacturer as part of clinical trials.

The Smart packaging solution from Schreiner MediPharm collects data in real time the moment the patient pushes a tablet out of the blister. For example, the medication type, the time of removal and the relevant cavity are recorded. The data is stored directly in the packaging. It can be transferred to a database via a smartphone app or using a special reading device.

Electronics printed directly onto blister packaging

The Connection to the database makes it possible to send patients reminders to take their medication, adjust the dose and support them in adhering to their therapy by means of interactive communication.

The electronic elements were printed directly onto the packaging using special processes. Schreiner MediPharm provides the expertise in innovative printing technology, ECCT the Intelligent sensor technology.

Display

[infotext icon]

Background: Accuracy in clinical trials is important

With the solution from Schreiner MediPharm, drug trials can run much more efficiently. Clinical trials must be conducted very accurately and reliably. It is essential that the test subjects take the preparations to be tested regularly as agreed. However, this is usually difficult to track. Any errors are virtually „priced in“ to the study designs. It is then assumed that 20 per cent of the income is missing. To compensate for this, the number of study participants is increased accordingly, by up to 60 per cent.

[/infotext]